News

VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6052 (RECOMBINANT HERPES ZOSTER VIRUS VACCINE (CHO CELLS)) OFFICIALLY INITIATED IN CHINA

November 02, 2026

a261102a_01.png

Copyright © CSPC PHARMACEUTICAL GROUP LIMITED All Rights Reserved | 冀ICP备05003393号

Wechat